didodecyldimethylammonium has been researched along with Cancer of Skin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carbone, C; Furneri, PM; Martins-Gomes, C; Musumeci, T; Pepe, V; Puglisi, G; Silva, AM; Souto, EB | 1 |
1 other study(ies) available for didodecyldimethylammonium and Cancer of Skin
Article | Year |
---|---|
Repurposing itraconazole to the benefit of skin cancer treatment: A combined azole-DDAB nanoencapsulation strategy.
Topics: Antineoplastic Agents; Azoles; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Itraconazole; Lipids; Nanoparticles; Particle Size; Quaternary Ammonium Compounds; Skin Neoplasms; Structure-Activity Relationship; Surface Properties | 2018 |